Insulin Hypersecretion as an Initiator of Insulin Resistance
Feb 2, 2021 5:50pm ‐ Feb 2, 2021 6:15pm
Speaker(s):
- Marc Prentki, PhD, Montreal Diabetes Research Center
Beta Cell Dysfunction Contributes to T1D
Feb 2, 2021 6:35pm ‐ Feb 2, 2021 7:00pm
Speaker(s):
- Lori Sussel, PhD, University of Colorado Anschutz Medical Campus
Short Talk: Targeting Beta Cell Unfolded Protein Response in T1D
Feb 2, 2021 7:00pm ‐ Feb 2, 2021 7:15pm
Speaker(s):
- Feyza Engin, PhD, University of Wisconsin-Madison
Short Talk: DNA Hydroxymethylation and Functional Beta Cell Mass in Health and Diabetes
Feb 2, 2021 7:15pm ‐ Feb 2, 2021 7:30pm
Speaker(s):
- Sangeeta Dhawan, PhD, City of Hope
Short Talk: Human Islet Microtissues as an in vitro and in vivo Model System for Diabetes
Feb 2, 2021 7:30pm ‐ Feb 2, 2021 7:45pm
Speaker(s):
- Joan Mir-Coll, PhD, InSphero AG
Short Talk: Modeling the Insulin Secretion Defects in MODY3 using Patient hIPSC-derived Beta Cells
Feb 2, 2021 7:45pm ‐ Feb 2, 2021 8:00pm
Speaker(s):
- Blaise Su Jun Low, BS, National University of Singapore
Have GWAS Helped Classify Diabetes?
Feb 3, 2021 10:00am ‐ Feb 3, 2021 10:25am
Speaker(s):
- Jose C. Florez, MD, PhD, Massachusetts General Hospital
Novel Therapeutic Strategies
Feb 3, 2021 10:00am ‐ Feb 3, 2021 1:00pm
Co-Chair(s):
- Juleen R. Zierath, PhD, Karolinska Institutet
- Jose C. Florez, MD, PhD, Massachusetts General Hospital
Subclassifying Diabetes by Combining GWAS and Clinical Phenotyping
Feb 3, 2021 10:25am ‐ Feb 3, 2021 10:50am
Speaker(s):
- Emma Ahlqvist, PhD, Lund University